Clinical Trial Update: A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of AND017 in patients with Myelodysplastic Syndromes and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING